Fig. 4From: COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health CenterPHQ-2 total scores at D14 vs. D28+ surveys (N = 199). PHQ-2 Total Score range is 0 to 6. PHQ-2, Patient Health Questionnaire-2Back to article page